Employees: NN (None)Legal category: 5485Size: NoneCreation date: 2009-12-01 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MALAKOFF (92240), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE REPPELIN : revenue, balance sheet and financial ratios
PHARMACIE REPPELIN is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MALAKOFF (92240),
this company of category PME
shows in 2021 a net income positive of 88 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE REPPELIN (SIREN 518870597)
Indicator
2021
2020
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
87 926 €
61 215 €
34 668 €
29 261 €
18 725 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2021, PHARMACIE REPPELIN generates positive net income of 88 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2021: 19 k€ -> 88 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
87 926 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 243%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
243.198%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
21.234%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
Debt ratio
293.141
214.314
161.042
326.248
243.198
Financial autonomy
20.353
26.157
32.208
17.452
21.234
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
243.22021
2018
2020
2021
Q1: 29.04
Med: 85.54
Q3: 208.43
Average+17 pts over 3 years
In 2021, the debt ratio of PHARMACIE REPPELIN (243.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
21.23%2021
2018
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Average-16 pts over 3 years
In 2021, the financial autonomy of PHARMACIE REPPELIN (21.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 96.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
96.966
Liquidity indicators evolution PHARMACIE REPPELIN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2020
2021
Liquidity ratio
128.346
129.788
142.438
96.778
96.966
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
96.972021
2018
2020
2021
Q1: 139.2
Med: 190.68
Q3: 259.61
Watch-21 pts over 3 years
In 2021, the liquidity ratio of PHARMACIE REPPELIN (96.97) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE REPPELIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE REPPELIN is estimated at
1 008 547 €
(range 648 501€ - 1 557 889€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
648k€1008k€1557k€
1 008 547 €Range: 648 501€ - 1 557 889€
NAF 5 année 2021
Valuation method used
Net Income Multiple
87 926 €
×
11.5x
=1 008 548 €
Range: 648 501€ - 1 557 889€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE REPPELIN with other companies in the same sector:
Frequently asked questions about PHARMACIE REPPELIN
What is the revenue of PHARMACIE REPPELIN ?
The revenue of PHARMACIE REPPELIN is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE REPPELIN profitable?
Yes, PHARMACIE REPPELIN generated a net profit of 88 k€ in 2021.
Where is the headquarters of PHARMACIE REPPELIN ?
The headquarters of PHARMACIE REPPELIN is located in MALAKOFF (92240), in the department Hauts-de-Seine.
Where to find the tax return of PHARMACIE REPPELIN ?
The tax return of PHARMACIE REPPELIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE REPPELIN operate?
PHARMACIE REPPELIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart